Impact of acute administration of escitalopram on the processing of emotional and neutral images: A randomized crossover fMRI study of healthy women

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 4, 2014, Pages 267-275

  Outhred, Tim ^a,b   Das, Pritha ^a,b   Felmingham, Kim L ^d   Bryant, Richard A ^e   Nathan, Pradeep J ^a,f,g   Malhi, Gin S ^a,b   Kemp, Andrew H ^a,b,c,h  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; EMOTIONALITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INFERIOR FRONTAL GYRUS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; BRAIN; BRAIN MAPPING; CROSSOVER PROCEDURE; DRUG EFFECTS; EMOTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOSTIMULATION; PHYSIOLOGY; VISION;

ADULT; BRAIN; BRAIN MAPPING; CITALOPRAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PHOTIC STIMULATION; SEROTONIN UPTAKE INHIBITORS; VISUAL PERCEPTION;

EID: 84904088394     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130118     Document Type: Article

References (65)

1. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry 2008;165:969-77.
2. Roiser JP, Elliott R, Sahakian BJ. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 2012;37:117-36.
3. Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of anti-depressant drug action. Br J Psychiatry 2009;195:102-8.
4. Pringle A, Browning M, Cowen PJ, et al. A cognitive neuropsycho-logical model of antidepressant drug action. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1586-92.
5. Kemp AH, Gordon E, Rush AJ, et al. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectrums 2008;13:1066-86.
6. Trivedi MH. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40.
7. Oliveira L, Ladouceur CD, Phillips ML, et al. What does brain response to neutral faces tell us about major depression? Evidence from machine learning and fMRI. PLoS ONE 2013;8:e60121.
8. Sheline YI, Barch DM, Donnelly JM, et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001;50:651-8.
9. Brunetti M, Sepede G, Mingoia G, et al. Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder: neural correlates of generalized emotional response. Neuroscience 2010; 168:670-9.
10. Kemp AH, Gray MA, Silberstein RB, et al. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysio-logical responses to visual emotional stimuli in humans. Neuroimage 2004;22:1084-96.
11. Murphy SE, Norbury R, O'Sullivan U, et al. Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 2009;194:535-40.
12. Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry 2013;47:74-87.
13. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55-68.
14. Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. J Affect Disord 1998;51:215-35.
15. Gillespie CF, Garlow S, Binder EB, et al. Neurobiology of mood disorders. In: Schatzberg AF, Nemeroff CB, editors. The American psychiatric publishing textbook of psychopharmacology. Arlington (VA): American Psychiatric Publishing; 2011.
16. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116-27.
17. Outhred T, Hawkshead BE, Wager TD, et al. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: implications for differential treatment efficacy. Neurosci Biobehav Rev 2013;37:1786-800.
18. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System (IAPS): affective ratings of pictures and instruction manual. Technical report A-8. Gainesville (FL): University of Florida; 2008.
19. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997;9:471-81.
20. Lee H, Heller AS, van Reekum CM, et al. Amygdala-prefrontal coupling underlies individual differences in emotion regulation. Neuroimage 2012;62:1575-81.
21. Luo Q, Holroyd T, Majestic C, et al. Emotional automaticity is a matter of timing. J Neurosci 2010;30:5825-9.
22. Pourtois G, Spinelli L, Seeck M, et al. Temporal precedence of emotion over attention modulations in the lateral amygdala: intracranial ERP evidence from a patient with temporal lobe epilepsy. Cogn Affect Behav Neurosci 2010;10:83-93.
23. Depue BE, Curran T, Banich MT. Prefrontal regions orchestrate suppression of emotional memories via a two-phase process. Science 2007; 317:215-9.
24. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001;24:167-202.
25. Banks SJ, Eddy KT, Angstadt M, et al. Amygdala frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci 2007;2:303-12.
26. Phan KL, Fitzgerald DA, Nathan PJ, et al. Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry 2005;57:210-9.
27. Wager TD, Davidson ML, Hughes BL, et al. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 2008; 59:1037-50.
28. Hamilton JP, Etkin A, Furman DJ, et al. Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of baseline activation and neural response data. Am J Psychiatry 2012;169:693-703.
29. Siegle GJ, Thompson W, Carter CS, et al. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007;61:198-209.
30. McCabe C, Mishor Z. Antidepressant medications reduce subcorticalcortical resting-state functional connectivity in healthy volunteers. Neuroimage 2011;57:1317-23.
31. Takahashi H, Yahata N, Koeda M, et al. Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. Neuroimage 2005;27:991-1001.
32. Godlewska BR, Norbury R, Selvaraj S, et al. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med 2012;42:2609-17.
33. Delaveau P, Jabourian M, Lemogne C, et al. Brain effects of anti-depressants in major depression: a meta-analysis of emotional processing studies. J Affect Disord 2011;130:66-74.
34. Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011; 36:183-206.
35. Norbury R, Mackay CE, Cowen PJ, et al. The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study. Mol Psychiatry 2008;13:1011-20.
36. Nathan PJ, Kemp AH, Harrison BJ. Antidepressants and emotional processing. Neuropsychopharmacology 2003;28:1383.
37. Harmer CJ, Mackay CE, Reid CB, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59:816-20.
38. Norbury R, Taylor MJ, Selvaraj S, et al. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl) 2009;206:197-204.
39. Brühl AB, Jäncke L, Herwig U. Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology (Berl) 2011;216:389-99.
40. Brühl AB, Kaffenberger T, Herwig U. Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology 2010;35:521-33.
41. McCabe C, Mishor Z, Cowen PJ, et al. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry 2010;67:439-45.
42. Britton JC, Taylor SF, Sudheimer KD, et al. Facial expressions and complex IAPS pictures: common and differential networks. Neuroimage 2006;31:906-19.
43. Hariri AR, Tessitore A, Mattay VS, et al. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 2002;17:317-23.
44. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65:193-207.
45. Mogg K, Bradley BP. Attentional bias in generalized anxiety disorder versus depressive disorder. Cognit Ther Res 2005;29:29-45.
46. Williams LM, Kemp AH, Felmingham K, et al. Neural biases to covert and overt signals of fear: dissociation by trait anxiety and depression. J Cogn Neurosci 2007;19:1595-608.
47. Cipriani A, Santilli C, Furukawa T, et al. Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009;(2):CD006532.
48. Montgomery SA, Baldwin DS, Blier P, et al. Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007;22:323-9.
49. Windischberger C, Lanzenberger R, Holik A, et al. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage 2010;49:1161-70.
50. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
51. Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
52. Søgaard B, Mengel H, Rao N, et al. The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. J Clin Pharmacol 2005;45:1400-6.
53. Alphapharm. Loxalate: product information [website of Alphapharm]. Sydney (AU): Alphapharm; 2012 Jan. p. 1-23. Available: www.mimsonline.com.au/MIMSData/en-AU /FullXML /pdf /man08076.pdf (accessed 2014 Mar. 26).
54. Mills EJ, Chan A-W, Wu P, et al. Design, analysis, and presentation of crossover trials. Trials 2009;10:27.
55. Senn S, D'Angelo G, Potvin D. Carry-over in cross-over trials in bioequivalence: theoretical concerns and empirical evidence. Pharm Stat 2004;3:133-42.
56. Lang PJ, Greenwald MK, Bradley MM, et al. Looking at pictures: affective, facial, visceral, and behavioral reactions. Psychophysiology 1993;30:261-73.
57. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-89.
58. Maldjian JA, Laurienti PJ, Kraft RA, et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233-9.
59. Bennett CM, Wolford GL, Miller MB. The principled control of false positives in neuroimaging. Soc Cogn Affect Neurosci 2009; 4:417-22.
60. Poldrack RA, Fletcher PC, Henson RN, et al. Guidelines for reporting an fMRI study. Neuroimage 2008;40:409-14.
61. Brett M, Anton J, Valabregue R, et al. Region of interest analysis using an SPM toolbox. 8th International Conference on Functional Mapping of the Human Brain; June 2-6, 2002; Sendai, Japan. Available: CD-ROM in NeuroImage 2002;16(2): abstract 497.
62. Di Simplicio M, Norbury R, Harmer CJ. Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression. Mol Psychiatry 2012;17:503-10.
63. Harmer C. Emotional processing and antidepressant action. In: Cowen PJ, Sharp T, Lau JYF, editors. Current topics in behavioral neurosciences. Berlin (DE): Springer; 2012:209-22.
64. Kret ME, De Gelder B. A review on sex differences in processing emotional signals. Neuropsychologia 2012;50:1211-21.
65. Kemp AH, Silberstein RB, Armstrong SM, et al. Gender differences in the cortical electrophysiological processing of visual emotional stimuli. Neuroimage 2004;21:632-46.